ONC HITAC Recommendations Feed Cross-Agency Public Health Data Work

Sept. 10, 2021
National Coordinator Micky Tripathi says ONC is working with CDC on an enterprise architecture for public health, FHIR roadmap

In July a task force of the Office of the National Coordinator for Health IT issued a report that included 22 recommendations related to public health data systems, infrastructure and standards. Now those recommendations are being considered by a federal cross-agency task force that's being driven by President Biden’s executive order to ensure a data-driven response to high-consequence public health threats.

During a press conference on Sept. 9, National Coordinator Micky Tripathi said the recommendations from the ONC Health Information Technology Advisory Committee’s Public Health Data Systems Task Force “were enormously helpful and pretty expansive.”

Among the recommendations were that “ONC should work with federal partners to create a preparedness plan and data standards for collecting information from within the health ecosystem during public health emergencies. The plan should enable public health to receive all necessary information while minimizing implementation and maintenance burden on all parties.”

HITAC also recommended that ONC should work with federal partners to “create a health data ecosystem plan that fully supports public health during response to high-consequence public health threats. The plan should create a healthcare paradigm shift where public health is a full partner and integral part of the healthcare ecosystem; changes implemented in healthcare should include a public health lens at the outset to ensure individual as well as population health needs are met and met in a manner that ensures health equity issues are captured comprehensively, respectfully, and illuminated by the data.”

Tripathi said that the ONC and the Centers for Disease Control are working together on high-priority elements that relate directly to some of the HITAC recommendations and findings. Tripathi added that they are thinking about what a public health architecture of the future would look like — something that would be like an enterprise architecture that could create more consistency across jurisdictions in the way that implementations happen. “Right now, there's a tremendous amount of heterogeneity across the jurisdictions,” he said, in part because state governments control much of what happens in public health. “But there still may be opportunities for us to be able to think about more enterprise types of approaches to architecture that will provide greater consistency in the way data is captured, the way data is stored, and the ability to have sharing of tools and analytics,” Tripathi explained, but still preserves the opportunity to allow local control by the jurisdiction of their data, and their applications.

Another area of exploration, he added, is the creation of a public health data model, building on the framework of the U.S. Core Data for Interoperability (USCDI), which Tripathi described as a minimum data set for the healthcare delivery system.

A third area of focus is developing a FHIR roadmap with the CDC. “We've been doing a lot of work pushing and promoting FHIR and making sure that it's available in the market as rapidly as possible,” he said. “The CDC has specific use cases that may lend themselves to FHIR-based approaches and FHIR-enabled technologies. A FHIR roadmap for public health could also be a part of a FHIR accelerator project with HL7 in the future.

A fourth topic under consideration, Tripathi added, is the role of TEFCA (the Trusted Exchange Framework and Common Agreement). “How do we have public health be a direct participant in nationwide interoperability networks? They don't participate today in Carequality or the Commonwell Health Alliance. How do we use TEFCA as a way of enabling public health to be a direct participant in that so they're not standing on the sidelines trying to get clinical data at a time of national and global emergency such as we've had and still having this pandemic?"

Tripathi also was asked whether the public health data systems work group he is co-chairing with the CDC was considering the idea that public health data systems should be certified in the way that EHRs are. “We're certainly looking at it, for sure,” he said, noting that public health departments can actually certify their systems today, for certain modules. A few states have put specific modules through ONC’s EHR certification program, but they're not required to. While it is certainly something that we're considering,” he said, “there are all sorts of questions about authorities, and whether that would impose a huge burden on the jurisdictions.”

Sponsored Recommendations

Care Access Made Easy: A Guide to Digital Self Service

Embracing digital transformation in healthcare is crucial, and there is no one-size-fits-all strategy. Consider adopting a crawl, walk, run approach to digital projects, enabling...

Powering a Digital Front Door with a Comprehensive Provider Directory

Learn how Geisinger improved provider data accuracy, SEO, and patient acquisition with a comprehensive provider directory.

Data-driven, physician-focused approach to CDI improvement

Organizational profile Sisters of Charity of Leavenworth (SCL) Health* has been providing care since it originated in the 1600s in France as the Daughters of Charity. These religious...

Luminis Health improved quality and financial outcomes with advanced CDI technology and consulting from 3M

In the beginning, there were challengesBefore partnering with 3M Health Information Systems (HIS), Luminis Health’s clinical documentation integrity (CDI) program faced ...

According to an Oct. 10 press release, a report by the World Health Organization (WHO) finds that vaccines against 24 pathogens could reduce the number of antibiotics needed by 22% or 2.5 billion defined daily doses globally every year, supporting worldwide efforts to address antimicrobial resistance (AMR). While some of these vaccines are already available but underused, others would need to be developed and brought to the market as soon as possible. AMR occurs when bacteria, viruses, fungi, and parasites no longer respond to antimicrobial medicines, making people sicker and increasing the risk of illness, death and the spread of infections that are difficult to treat. AMR is driven largely by the misuse and overuse of antimicrobials, yet, at the same time, many people around the world do not have access to essential antimicrobials. Each year, nearly 5 million deaths are associated with AMR globally. Vaccines are an essential part of the response to reduce AMR as they prevent infections, reduce the use and overuse of antimicrobials, and slow the emergence and spread of drug-resistant pathogens. The new report expands on a WHO study published in BMJ Global Health last year. It estimates that vaccines already in use against pneumococcus pneumonia, Haemophilus influenzae type B (Hib, a bacteria causing pneumonia and meningitis) and typhoid could avert up to 106 000 of the deaths associated with AMR each year. An additional 543 000 deaths associated with AMR could be averted annually when new vaccines for tuberculosis (TB) and Klebsiella pneumoniae, are developed and rolled out globally. While new TB vaccines are in clinical trials, one against Klebsiella pneumoniae is in early stage of development.
dreamstime_xxl_210174616_1